PMFLIST Archives

November 2019


Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
PICKERING Brian <[log in to unmask]>
Reply To:
The Pharmaceutical Microbiology Forum Email List <[log in to unmask]>
Wed, 13 Nov 2019 19:53:33 +0000
text/plain (1744 bytes) , image001.jpg (1707 bytes)
Hello All-with Steris discontinuing the current formulations of phenolic disinfectants LpH II and Vesphene II in favor of new formulations Vesphene III and LpH III which do not contain PTAP (p-tert-Amylphenol), do folks see the need to re-execute coupon disinfection efficacy studies or can these new formulations (which are very similar to originals) be qualified in-situ only?
Thank you

Brian Pickering
Associate Director-QC| Microbiology, RM
O: (508) 370-5156 | C: (508) 963-3682<>

The PMFList ( is operated from
The Microbiology Network ( and supported by
our sponsors as a service to the scientific community.

Please take a second to visit our sponsors' web sites and say thank you for their support of this service.
If your company would be interested in sponsoring this community, please contact [log in to unmask]

Science Advisory Board

Steris -

Charles River Laboratories -

Veltek Associates, Inc -

Microbiologics, Inc. -

BD Industrial Media -

Boston Analytical

Associates of Cape Cod, Inc. -

The nature of this service is to provide a medium for communication.  The specific statements and endorsements of individuals participating in the discussions are not necessarily those of The Microbiology Network, Inc., the PMF, or the sponsors of the list.